Zhou, L., McMahon, C., Bhagat, T., Alencar, C., Yu, Y., Fazzari, M., . . . Verma, A. (2010). Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase.
Παραπομπή Chicago StyleZhou, L., et al. Reduced SMAD7 Leads to Overactivation of TGF-beta Signaling in MDS That Can Be Reversed By a Specific Inhibitor of TGF-beta Receptor I Kinase. 2010.
Παραπομπή MLAZhou, L., et al. Reduced SMAD7 Leads to Overactivation of TGF-beta Signaling in MDS That Can Be Reversed By a Specific Inhibitor of TGF-beta Receptor I Kinase. 2010.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.